Retatrutide

Retatrutide is a novel triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. Research has demonstrated significant effects on metabolic parameters, energy expenditure, and body composition in preclinical and clinical models.

Research Areas

Metabolic researchBody compositionAppetite signalingEnergy expenditure

Select Size

Research Use Only. This compound is sold strictly for laboratory and research purposes. Not for human consumption. Certificate of Analysis included with every order.

Third-Party Tested

COA Included

Secure Checkout

Storage Instructions

Store lyophilized peptide at -20°C. After reconstitution, store at 4°C for up to 4 weeks.

Related Compounds

View All

Weight Loss

Tirzepatide

Dual GIP and GLP-1 receptor agonist extensively studied for metabolic regulation and glucose homeostasis.

From $144.99View

Weight Loss

MOTS-C

Mitochondrial-derived peptide studied for metabolic regulation, insulin sensitivity, and exercise mimetics.

From $72.99View

Weight Loss

AOD 9604

Modified fragment of human growth hormone studied for lipolytic and anti-lipogenic properties in research models.

From $39.99View